Schloer, S., Brunotte, L., Goretzko, J., Mecate-Zambrano, A., Korthals, N., Gerke, V., . . . Rescher, U. (2020). Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Emerg Microbes Infect.
Παραπομπή Chicago StyleSchloer, Sebastian, Linda Brunotte, Jonas Goretzko, Angeles Mecate-Zambrano, Nadia Korthals, Volker Gerke, Stephan Ludwig, και Ursula Rescher. "Targeting the Endolysosomal Host-SARS-CoV-2 Interface By Clinically Licensed Functional Inhibitors of Acid Sphingomyelinase (FIASMA) Including the Antidepressant Fluoxetine." Emerg Microbes Infect 2020.
Παραπομπή MLASchloer, Sebastian, et al. "Targeting the Endolysosomal Host-SARS-CoV-2 Interface By Clinically Licensed Functional Inhibitors of Acid Sphingomyelinase (FIASMA) Including the Antidepressant Fluoxetine." Emerg Microbes Infect 2020.